Christopher Peetz
2022
In 2022, Christopher Peetz earned a total compensation of $4.4M as President and Chief Executive Officer at Mirum Pharmaceuticals, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $449,280 |
|---|---|
| Option Awards | $2,682,384 |
| Salary | $624,000 |
| Stock Awards | $634,800 |
| Other | $12,200 |
| Total | $4,402,664 |
Peetz received $2.7M in option awards, accounting for 61% of the total pay in 2022.
Peetz also received $449.3K in non-equity incentive plan, $624K in salary, $634.8K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Christopher Peetz's compensation ranked 754th out of 5,756 executives tracked by ExecPay. In other words, Peetz earned more than 86.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 754 out of 5,756 | 87th |
Division Manufacturing | 336 out of 3,133 | 89th |
Major group Chemicals And Allied Products | 108 out of 1,419 | 92nd |
Industry group Drugs | 95 out of 1,320 | 93rd |
Industry Pharmaceutical Preparations | 70 out of 966 | 93rd |
Source: SEC filing on May 1, 2023.
Peetz's colleagues
We found three more compensation records of executives who worked with Christopher Peetz at Mirum Pharmaceuticals in 2022.
News
Mirum Pharmaceuticals CEO Christopher Peetz's 2023 pay jumps 47% to $6.5M
April 23, 2024
Mirum Pharmaceuticals CEO Christopher Peetz's 2022 pay rises 7% to $4.4M
May 1, 2023
Mirum Pharmaceuticals CEO Christopher Peetz's 2021 pay jumps 38% to $4.1M
April 22, 2022
Mirum Pharmaceuticals CEO Christopher Peetz's 2020 pay falls 52% to $3M
April 14, 2021